SCHEMBL6576231

SCHEMBL6576231

Cc1ccc2cc(OCc3c(Cl)ccc([N+](=O)[O-])c3C#N)ccc2n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
HIF1A Q16665 1/20 0.39
S1PR4 O95977 5/20 0.37
HTR1A P08908 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
VCAM1 P19320 1/20 0.34
LMNA P02545 2/20 0.34
NPC1 O15118 1/20 0.34
HPGD P15428 1/20 0.34
NQO1 P15559 1/20 0.34
ALDH1A1 P00352 4/20 0.34
MERTK Q12866 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6581287 0.87 MAPT (0.42) MAPTSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6581385 0.87 TP53 (0.42) MAPTSMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6576127 0.84 S1PR4 (0.42) MAPTSMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6576073 0.83 KDM4E (0.38) MAPTCYP3A4CYP2D6LMNANPC1
SCHEMBL6576229 0.78 BDKRB2 (0.54) ALDH1A1MEN1KMT2A
SCHEMBL6581453 0.78 ALDH1A1 (0.40) MAPTSMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6580686 0.78 S1PR4 (0.44) MAPTSMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6580688 0.75 ALDH1A1 (0.36) MAPTSMN1; SMN2TP53CYP1A2CYP3A4
SCHEMBL6578371 0.75 ALDH1A1 (0.44) MAPTSMN1; SMN2CYP1A2CYP2D6CYP2C9
SCHEMBL6578500 0.73 ALDH1A1 (0.43) MAPTSMN1; SMN2CYP1A2CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0867432-B1 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists AVENTIS PHARMA GMBH (DE) 2004-06-09 EP disclosed
EP-0867432-A2 Fused N-heterocyclic compounds substituted with benzyloxy, process for their preparation and their use as bradykinin receptor antagonists HOECHST AKTIENGESELLSCHAFT (DE) 1998-09-30 EP disclosed